Primer probe combination for detecting methylation double sites of colorectal cancer and kit thereof
By combining primer and probe combinations for SDC2 and LIFR two-site detection and using molecular hybridization capture technology, the problem of low sensitivity in colorectal cancer screening has been solved, achieving high sensitivity and high specificity for early screening, which is suitable for early colorectal cancer screening of fecal samples.
Patent Information
- Application Number
- CN202211594794.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-13
- Publication Date
- 2026-06-02
- Estimated Expiration
- 2042-12-13
AI Technical Summary
Existing colorectal cancer screening methods have low sensitivity, high false negative rates for single methylation site detection, and lack highly sensitive and specific combined detection methods.
A primer-probe combination for joint detection of SDC2 and LIFR sites was used, combined with molecular hybridization capture and multiplex fluorescent PCR technology, to detect the methylation sites cg08392199 of the LIFR gene and cg13096260 of the SDC2 gene in fecal samples. The target genes were captured by probe specificity and analyzed by real-time fluorescent PCR.
It achieves high sensitivity (92%) and high specificity (100%) in colorectal cancer detection, providing a high-sensitivity and high-specificity early screening method. It is fast, easy to operate, and low-cost, making it suitable for early colorectal cancer screening.